Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
BEFREE |
Our clinical case supports the hypothesis that CHD8 may play a central role in neuronal cell development and ASD risk.
|
26921529 |
2016 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
CLINGEN |
REST activation was also observed in the brains of humans with ASD, and CHD8 was found to interact physically with REST in the mouse brain.
|
27602517 |
2016 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
BEFREE |
Recently, disruptive CHD8 mutations were described in patients with similar phenotypes further showing pivotal role of CHD8 gene in the pathogenesis of DD/ID or ASDs.
|
26834018 |
2016 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
BEFREE |
These results suggest that CHD8 insufficiency may be a central hub in neuronal development and ASD risk.
|
25989142 |
2015 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
BEFREE |
Finally, analyses of the CHD8 subnetwork and altered transcript levels from an independent study of CHD8 suppression further confirmed the central role of genes regulating neurogenesis and cell adhesion processes in ASD brain maldevelopment.
|
26668231 |
2015 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
BEFREE |
These results suggest loss of CHD8 contributes to ASD by perturbing an ancient gene regulatory network during human brain development.
|
25752243 |
2015 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.
|
24998929 |
2014 |
Autism Spectrum Disorders
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Notably, recent studies also disclosed CHD8 heterozygous loss-of-function mutations in patients with ASD and macrocephaly.
|
25257502 |
2014 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
BEFREE |
Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.
|
24998929 |
2014 |
Autism Spectrum Disorders
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genes associated with ASD were strongly enriched among indirectly down-regulated loci (P < 10(-8)) and CHD8-bound genes (P = 0.0043), which align with previously identified coexpression modules during fetal development.
|
25294932 |
2014 |
Autism Spectrum Disorders
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The most interesting genes included in this deletion are CHD8, a chromodomain helicase DNA binding protein that is associated with autism spectrum disorders, and MMP14, a matrix metalloproteinase that has been linked to obesity and type 2 diabetes.
|
24243641 |
2014 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
CTD_human |
Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.
|
24998929 |
2014 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway.
|
22083958 |
2012 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.
|
22495309 |
2012 |
Autism Spectrum Disorders
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our data support associations between specific genes and reciprocal subphenotypes (CHD8-macrocephaly and DYRK1A-microcephaly) and replicate the importance of a β-catenin-chromatin-remodeling network to ASD etiology.
|
23160955 |
2012 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
BEFREE |
Because identification of novel CHD7 and CHD8 interacting partners will provide further insights into the pathogenesis of CHARGE syndrome and ASD/NDD, we searched for additional associated polypeptides using the method of stable isotope labeling by amino acids in cell culture (SILAC) in combination with mass spectrometry.
|
23285124 |
2012 |
Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
MGD |
|
|
|
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
CHD8 has been reported as an autism susceptibility/intellectual disability gene but emerging evidence suggests that it additionally causes an overgrowth phenotype.
|
31721432 |
2019 |
Autistic Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the CHD2 gene have been linked to developmental delay, intellectual disability, autism and seizures, CHD8 mutations to autism and intellectual disability, whereas haploinsufficiency of CHD7 is associated with executive dysfunction and intellectual disability.
|
30277262 |
2018 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
Autism-associated CHD8 deficiency impairs axon development and migration of cortical neurons.
|
30574290 |
2018 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
The chromatin remodeling gene CHD8 represents a central node in neurodevelopmental gene networks implicated in autism.
|
28671691 |
2017 |
Autistic Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This case report supports the association of CHD8 mutations with classical autism, macrocephaly, infantile hypotonia, speech delay, lack of major ID, and psychopathology in late adolescence caused by insufficient dosage of CHD8.
|
26789910 |
2016 |
Autistic Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We describe a single case of an intragenic deletion of exons 26-28 in the CHD8 gene in a patient with autism and global developmental delay.
|
26921529 |
2016 |
Autistic Disorder
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): A case report and literature review.
|
26789910 |
2016 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment.
|
25752243 |
2015 |